Superficial Basal Cell Carcinoma — Trials

Superficial Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

18 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 40%
Top sponsor: Biofrontera Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03573401	Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).	active not recruiting	Phase 3	187	Biofrontera Inc.INDUSTRY	1	Jan 14, 2026	clinicaltrials
NCT05381597	5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer	recruiting	Phase 2 / Phase 3	200	Boston UniversityOTHER	1	Nov 28, 2025	clinicaltrials